Professional
Added to YB: 2024-06-06
Pitch date: 2024-05-28
BSX [bullish]
Boston Scientific Corporation
+1.26%
current return
Author Info
No bio for this author
Company Info
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide.
Market Cap
$113.1B
Pitch Price
$74.78
Price Target
95.00 (+25%)
Dividend
N/A
EV/EBITDA
22.17
P/E
39.32
EV/Sales
6.18
Sector
Health Care Equipment and Supplies
Category
growth
Boston Scientific Corporation: Raising target to $95
BSX: Raising PT to $95 on strong growth in innovative medtech supported by new products & M&A. Raised 2024 rev growth & EPS guidance after robust Q1. Farapulse launch for AF a key 2024 driver. Expanding in Japan, China, Europe. Medium-High financial strength. Risks: competition, regulation, M&A.
Read full article (4 min)